Acyclovir and Anzemet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir (acyclovir) and Anzemet (dolasetron mesylate). Common drug interactions include impaired healing among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Anzemet. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.



On Jul, 14, 2026

38 people who take Acyclovir and Anzemet together, and have interactions are studied.

Acyclovir and Anzemet drug interactions.

What are the common drug interactions of Acyclovir and Anzemet, by gender? *:

female:

  1. Impaired healing
  2. Infection
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Asthma
  7. Bone density decreased
  8. Bone marrow failure
  9. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  10. Cough

male:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Pneumonia
  3. Asthenia (weakness)
  4. Back pain
  5. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  6. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  7. Chest pain
  8. Dental caries
  9. Dizziness
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Acyclovir and Anzemet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Pyrexia (fever)
  3. Pneumonia
  4. Acidosis (build-up of carbon dioxide in the blood)
  5. Anaemia (lack of blood)
  6. Anxiety
  7. Arthralgia (joint pain)
  8. Asthenia (weakness)
  9. Back pain
  10. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)

50-59:

  1. Atrophic vulvovaginitis (inflammation of the vulva)
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Decreased appetite
  4. Exposed bone in jaw
  5. Fistula (an abnormal connection or passageway between two)
  6. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  7. Hyperglycaemia (high blood sugar)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Lymph node calcification (calcium deposit in lymph node)
  10. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Pneumonia primary atypical (primary atypical pneumonia which were probably caused by mycoplasma pneumoniae)
  5. Aplasia (defective development or congenital absence of an organ or tissue)
  6. Biliary tract disorder
  7. Bone marrow failure
  8. Cholecystitis (infection of gallbladder)
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Colonic polyp (extra part of colon tissue grow in intestine)

What are the existing conditions these people have? *

  1. Depression: 5 people, 13.16%
  2. Anaemia (lack of blood): 5 people, 13.16%
  3. Breast Cancer: 5 people, 13.16%
  4. Joint Pain: 5 people, 13.16%
  5. Breast Cancer Recurrent: 5 people, 13.16%
  6. Sleep Disorder: 5 people, 13.16%
  7. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 10.53%
  8. Nausea (feeling of having an urge to vomit): 4 people, 10.53%
  9. Multiple Myeloma (cancer of the plasma cells): 4 people, 10.53%
  10. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and Anzemet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acyclovir and Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Anzemet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acyclovir and dolasetron mesylate (the active ingredients of Acyclovir and Anzemet, respectively), and Acyclovir and Anzemet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: